Literature DB >> 16880511

Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein.

Abdelmajid Sabile1, Andrea Michael Meyer, Christiane Wirbelauer, Daniel Hess, Ulrike Kogel, Martin Scheffner, Wilhelm Krek.   

Abstract

Ubiquitin-mediated degradation of the cyclin-dependent kinase inhibitor p27 provides a powerful route for enforcing normal progression through the mammalian cell cycle. According to a current model, the ubiquitination of p27 during S-phase progression is mediated by SCF(Skp2) E3 ligase that captures Thr187-phosphorylated p27 by means of the F-box protein Skp2, which in turn couples the bound substrate via Skp1 to a catalytic core complex composed of Cul1 and the Rbx/Roc RING finger protein. Here we identify Skp2 as a component of an Skp1-cullin-F-box complex that is based on a Cul1-Ro52 RING finger B-box coiled-coil motif family protein catalytic core. Ro52-containing complexes display E3 ligase activity and promote the ubiquitination of Thr187-phosphorylated p27 in a RING-dependent manner in vitro. The knockdown of Ro52 expression in human cells with small interfering RNAs causes the accumulation of p27 and the failure of cells to enter S phase. Importantly, these effects are abrogated by the simultaneous removal of p27. Taken together, these data suggest a key role for Ro52 RING finger protein in the regulation of p27 degradation and S-phase progression in mammalian cells and provide evidence for the existence of a Cul1-based catalytic core that utilizes Ro52 RING protein to promote ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880511      PMCID: PMC1592794          DOI: 10.1128/MCB.01630-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

Review 1.  RING for destruction?

Authors:  P S Freemont
Journal:  Curr Biol       Date:  2000-01-27       Impact factor: 10.834

2.  A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.

Authors:  C Spruck; H Strohmaier; M Watson; A P Smith; A Ryan; T W Krek; S I Reed
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

3.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.

Authors:  H Sutterlüty; E Chatelain; A Marti; C Wirbelauer; M Senften; U Müller; W Krek
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

4.  The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.

Authors:  D Ganoth; G Bornstein; T K Ko; B Larsen; M Tyers; M Pagano; A Hershko
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

5.  Skp2 is oncogenic and overexpressed in human cancers.

Authors:  M Gstaiger; R Jordan; M Lim; C Catzavelos; J Mestan; J Slingerland; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

6.  Role of the F-box protein Skp2 in lymphomagenesis.

Authors:  E Latres; R Chiarle; B A Schulman; N P Pavletich; A Pellicer; G Inghirami; M Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

7.  Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines.

Authors:  K H Moberg; D W Bell; D C Wahrer; D A Haber; I K Hariharan
Journal:  Nature       Date:  2001-09-20       Impact factor: 49.962

8.  The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.

Authors:  C Wirbelauer; H Sutterlüty; M Blondel; M Gstaiger; M Peter; F Reymond; W Krek
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

9.  Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells.

Authors:  A Hengstermann; L K Linares; A Ciechanover; N J Whitaker; M Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

10.  The tripartite motif family identifies cell compartments.

Authors:  A Reymond; G Meroni; A Fantozzi; G Merla; S Cairo; L Luzi; D Riganelli; E Zanaria; S Messali; S Cainarca; A Guffanti; S Minucci; P G Pelicci; A Ballabio
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

View more
  36 in total

1.  Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome.

Authors:  Rodger E Tiedemann; Yuan Xao Zhu; Jessica Schmidt; Chang Xin Shi; Chris Sereduk; Hongwei Yin; Spyro Mousses; A Keith Stewart
Journal:  Cancer Res       Date:  2011-12-06       Impact factor: 12.701

2.  Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production.

Authors:  Jennifer A Young; Decha Sermwittayawong; Hee-Jung Kim; Suruchi Nandu; Namsil An; Hediye Erdjument-Bromage; Paul Tempst; Laurent Coscoy; Astar Winoto
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

3.  ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets.

Authors:  Jessie Villanueva; Yuval Yung; Janice L Walker; Richard K Assoian
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

4.  Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts.

Authors:  Ryusuke Yoshimi; Tsung-Hsien Chang; Hongsheng Wang; Toru Atsumi; Herbert C Morse; Keiko Ozato
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies.

Authors:  Linn Strandberg; Aurelie Ambrosi; Alexander Espinosa; Lars Ottosson; Maija-Leena Eloranta; Wei Zhou; Ase Elfving; Edward Greenfield; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

6.  IKK-β/NF-κB p65 mediates p27(Kip1) protein degradation in arsenite response.

Authors:  Wei Guo; Jinyi Liu; Jinlong Jian; Jingxia Li; Yu Wan; Chuanshu Huang
Journal:  Biochem Biophys Res Commun       Date:  2014-04-18       Impact factor: 3.575

7.  E2/Estrogen receptor/sjogren syndrome-associated autoantigen relieves coactivator activator-induced G1/S arrest to promote breast tumorigenicity.

Authors:  Yun Kyoung Kang; Sung Yun Jung; Jun Qin; Chao Li; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

8.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

Review 9.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

10.  Proteomic snapshot of breast cancer cell cycle: G1/S transition point.

Authors:  Milagros J Tenga; Iulia M Lazar
Journal:  Proteomics       Date:  2013-01       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.